image
Inovio Pharmaceuticals, Inc. INO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.265
-10.6 %
$ 111 M
Market Cap
-0.84
P/E
CASH FLOW STATEMENT
-124 M OPERATING CASH FLOW
42.48%
Growth Rates
1Year 42.48%
3Years 11.26%
5Years -11.08%
7Years -10.31%
10Years -23.25%
87.4 M INVESTING CASH FLOW
-20.29%
Growth Rates
1Year -20.29%
3Years 51.62%
5Years 15.54%
7Years 27.13%
10Years 27.62%
5 M FINANCING CASH FLOW
-93.90%
Growth Rates
1Year -93.90%
3Years -77.94%
5Years -30.60%
7Years -6.15%
10Years -20.99%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Inovio Pharmaceuticals, Inc.
image
Net Income -135 M
Depreciation & Amortization 3.5 M
Capital Expenditures -321 K
Stock-Based Compensation 11.1 M
Change in Working Capital -10.3 M
Others 32.9 M
Free Cash Flow -125 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Mar-2001 Mar-2000 Mar-1999
OPERATING CASH FLOW
Net Income (135.1) (279.8) (303.7) (167.5) (120.6) (97.0) (88.2) (73.7) (29.1) (36.1) (66.1) (19.7) (15.3) (17.6) (24.5) (13.0) (11.2) (12.5) (15.3) (11.3) (6.6) (6.0) (8.6) (9.6) (6.6)
Depreciation & Amortization 3.5 5.5 4.7 4.6 5.5 5.0 3.5 3.1 1.9 1.6 2.1 2.0 2.0 2.1 1.7 1.0 1.0 0.9 0.8 0.6 0.6 0.6 0.7 0.6 0.4
Deferred Income Tax 32 K 4.0 5.7 37.9 (0.3) 3.4 (0.2) 849 (2.1) 27.5 K 32.3 K 22.8 K 53.2 K 53.2 K (0.9) (63 000.0) (63 000.0) 63 K 57.8 K (0.4) (0.2) 5.9 (0.2) 0 0
Stock Based Compensation 11.1 22.6 26.3 15.6 10.9 10.7 13.1 10.5 6.2 5.4 1.9 1.3 1.7 1.2 2.2 1.1 1 702 809.0 1.4 0.1 0.4 0.2 0.1 0.2 0 0
Other Operating Activities 6.5 11.7 0.9 2.4 10.1 (0.4) 5.7 (1.8) (3.0) (2.9) 45.0 (4.8) (6.9) (1.3) 11.1 62 999.9 (1 639 809.6) 0.2 3.4 0.6 3.2 (5.8) 49.6 K 0.1 100 K
Change in Working Capital (10.3) 19.8 50.4 (71.1) (3.5) 4.7 2.9 (0.5) 13.6 2.2 1.7 (1.2) (1.3) 3.6 (3.7) (0.2) (0.6) 2.9 (1.3) 3.2 38.9 K 0.2 (0.3) 0.1 (0.2)
Cash From Operations (124.4) (216.2) (215.7) (178.0) (97.9) (73.6) (63.2) (62.6) (12.4) (29.8) (15.4) (22.3) (19.8) (11.9) (14.1) (11.1) (11.5) (7.0) (12.3) (6.8) (2.7) (5.0) (8.4) (8.8) (6.3)
INVESTING CASH FLOW
Capital Expenditures (0.3) (1.0) (1.2) (1.5) (1.0) (2.1) (10.3) (3.9) (2.8) (1.4) (0.2) (0.2) (0.2) (0.3) (0.2) (0.6) (0.6) (1.4) (0.3) (0.1) 59.6 K (0.4) (0.3) (0.3) (0.5)
Other Items 87.7 110.6 (174.1) (57.3) (8.1) 44.5 (17.5) 20.2 (52.0) (34.4) (9.1) 5.5 (10.7) 11.7 1.6 3.5 (2.2) (14.7) (2.8) (0.3) (0.3) 19.6 K (3.1) (0.5) (0.3)
Cash From Investing Activities 87.4 109.6 (175.3) (58.8) (9.0) 42.4 (27.8) 16.3 (54.8) (35.8) (9.2) 5.3 (10.9) 11.4 1.4 2.9 (2.8) (16.1) (3.1) (0.4) (0.3) (0.4) (3.4) (0.8) (0.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0.2 97.4 0 0 0 0 0 0 0 0 (12.2) (0.2) 12.1 36 K 0 0 0 20.6 K 27.5 K 0 58.3 K 45.9 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23.3 K (0.1) (0.6) (0.3) 0 0 0 0 0
Other Financing Activities (0.5) (1.1) 2.1 10.6 (1.1) 1.8 1.3 1.5 2.4 13.3 19.8 0 15.9 K 0.2 0.4 50 K 0 0 0 0 0 3.9 5.7 7.4 4.9
Cash From Financing Activities 5.0 81.8 211.5 465.3 105.4 31.0 95.7 7.8 84.4 72.5 52.7 5.3 28.0 (9.7) 28.6 12.2 16.3 14.2 14.7 11.7 15.7 4.6 5.7 13.1 6.9
CHANGE IN CASH
Net Change In Cash (32.0) (24.8) (179.6) 228.5 (1.5) 92.9 K 4.7 (38.5) 17.1 6.8 28.1 (11.7) (2.6) (10.3) 16.2 3.9 1.9 (8.8) (0.7) 4.4 12.6 (0.9) (6.0) 3.6 (0.3)
FREE CASH FLOW
Free Cash Flow (124.7) (217.2) (216.9) (179.5) (98.8) (75.6) (73.5) (66.5) (15.2) (31.2) (15.6) (22.5) (19.9) (12.2) (14.2) (11.7) (12.2) (8.4) (12.6) (6.9) (2.8) (5.4) (8.6) (9.1) (6.8)